| # | Drug | Count |
|---|---|---|
| 0 | ATAZANAVIR | 29 |
| 1 | RITONAVIR | 29 |
| 2 | DARUNAVIR | 28 |
| 3 | NEVIRAPINE | 19 |
| 4 | LEVETIRACETAM | 14 |
| 5 | LEVETIRACETAM IN SODIUM CHLORIDE | 13 |
| 6 | LEVETIRACETAM INJECTION | 13 |
| 7 | LEVETIRACETAM ORAL | 13 |
| 8 | LACOSAMIDE | 12 |
| 9 | OLANZAPINE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ABACAVIR AND LAMIVUDINE | 1 | 0.0050 |
| 1 | CARBAMIDE PEROXIDE | 1 | 0.0023 |
| 2 | NEVIRAPINE | 19 | 0.0021 |
| 3 | ATAZANAVIR | 29 | 0.0020 |
| 4 | DARUNAVIR | 28 | 0.0019 |
| 5 | DINOPROSTONE | 1 | 0.0012 |
| 6 | TERCONAZOLE | 1 | 0.0012 |
| 7 | TEPROTUMUMAB | 4 | 0.0007 |
| 8 | LAMIVUDINE AND ZIDOVUDINE | 4 | 0.0005 |
| 9 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 19 | 0.0008 |
| 2 | Protease Inhibitor [EPC] | 31 | 0.0007 |
| 3 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 4 | 0.0007 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 31 | 0.0005 |
| 5 | Oxytocic [EPC] | 1 | 0.0003 |
| 6 | Vitamin K [EPC] | 2 | 0.0002 |
| 7 | Recombinant Human Deoxyribonuclease 1 [EPC] | 3 | 0.0002 |
| 8 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 8 | 0.0001 |